TREATMENT OF ADVANCED OVARIAN CANCER WITH CIS-DICHLORODIAMMINEPLATINUM(II) - POOR-RISK PATIENTS WITH INTENSIVE PRIOR THERAPY

Google Scholar
  • 1 January 1978
    • journal article
    • research article
    • Vol. 62  (4) , 555-558
Abstract
Patients (19) with advanced ovarian adenocarcinoma were treated with cis-dichlorodiammineplatinum(II) (DDP), 50 mg/m2 as an i.v. bolus once every 3 wk. Prior treatment exhausted other chemotherapeutic options or damaged the bone marrow sufficiently to contraindicate treatment with standard drugs. All patients had evaluable tumors and evidence of failure of prior therapy. DDP produced objective responses, relieved symptoms due to tumor and improved the patients'' quality of survival. There were no serious hematologic complications due to therapy except anemia.